Steven J. Meyer, Director at Insys Therapeutics, Inc. (INSY), bought 5,000 shares at $21.38 ($107K) on 2014-05-15, disclosed to the SEC on 2014-05-15.
Open-market purchase of $107k INSY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AKRX | BUY | 2019-05-30 | $38K | — | Filing → |
| AKRX | BUY | 2019-05-22 | $123K | — | Filing → |
| INSY | BUY | 2017-05-18 | $98K | — | Filing → |